Recent Analyst Forecasts and Stock Ratings
Definium Therapeutics Inc. FAQ's
Definium Therapeutics Inc. has been rated by research analysts at Canaccord Genuity, UBS, Robert W. Baird, Oppenheimer, Maxim Group, RBC Capital in the past 90 days.
Definium Therapeutics Inc. has been rated by research analysts at Canaccord Genuity, UBS, Robert W. Baird, Oppenheimer, Maxim Group, RBC Capital in the past 90 days.